SYDNEY BREWER: Open Payments
NPI 1861176273 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,217 in 151 payments from 19 companies in 2025. Trend: 2023 $2,243 · 2024 $6,221 · 2025 $4,217
Food & beverage: $4,104Education: $113
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 18 | $611 |
| Janssen Biotech, Inc. | 19 | $597 |
| Incyte Corporation | 12 | $424 |
| ABBVIE INC. | 30 | $380 |
| Galderma Laboratories, L.P. | 7 | $361 |
| Organogenesis Inc. | 5 | $357 |
| UCB, Inc. | 18 | $314 |
| GENZYME CORPORATION | 13 | $280 |
| Amgen Inc. | 6 | $223 |
| Organon LLC | 4 | $195 |
Products named: DUPIXENT, TREMFYA, NEMLUVIO, Bimzelx, OPZELURA, Otezla, SKYRIZI, RINVOQ.
Industry payments across GA — which companies pay providers there.
